lumpectomy is a surgical procedure performed to remove a discrete mass or tumor from the breast while preserving the maximum amount of surrounding healthy breast tissue, commonly referred to as breast-conserving surgery (BCS). It is distinguished from a mastectomy, which involves the complete removal of the breast tissue, and from an excisional biopsy, which is primarily diagnostic rather than therapeutic. The underlying mechanism involves the targeted surgical excision of the lesion, often guided by preoperative wire placement, radioactive seeds, or magnetic markers if the mass is non-palpable, followed by pathological evaluation to ensure clear (negative) surgical margins. While it is a pathological intervention used to treat malignant neoplasms (C50.x) or remove symptomatic benign tumors (D24.x), it relies on normal physiological wound healing and is frequently followed by adjuvant radiation therapy to reduce local recurrence. Clinically relevant subtypes include wide local excision (WLE) and quadrantectomy, which involves removing an entire quadrant of the breast (C50.x). It is most commonly confused with an excisional breast biopsy; the key difference is that a lumpectomy is performed with therapeutic intent to achieve clear margins (usually after a diagnosis is established), whereas a biopsy is performed to obtain tissue for an initial diagnosis.
Noun-forming suffix — “surgical excision or removal of”
The word entered English in the 1930s as lumpectomy (noun), coined as a hybrid of the Middle English lumpe and the Greek suffix ektomē — literally “excision of a lump.” The term gained widespread clinical acceptance in the 1970s and 1980s as breast-conserving surgery became a standard alternative to radical mastectomy. The root ektomē (“excision”) connects lumpectomy to the entire -ectomy: mastectomy (breast excision → removal of the breast), appendectomy (appendix excision → removal of the appendix), and thyroidectomy (removal of the thyroid gland). The suffix -ectomy is highly productive in medical terminology, appearing in procedures such as prostatectomy, vitrectomy, and laryngectomy.
🔀 ALIASES / ALTERNATE TERMS
lumpectomy-related(adjective form — e.g., “lumpectomy cavity,” “lumpectomy margins”)
Breast-conserving surgery (BCS)(lay and clinical term; widely used in oncology and surgical settings to describe the overarching goal of the procedure)
Partial mastectomy(CPT descriptor synonym; the formal terminology used in the CPT codebook for this procedure)
Wide local excision (WLE)(clinical descriptor synonym; often used interchangeably, emphasizing the removal of the lesion with a margin of normal tissue)
Tylectomy(Greek-derived synonym; rare in modern clinical practice but historically used to mean excision of a lump or tumor; D24.x, C50.x)
Quadrantectomy(anatomic subtype; a more extensive form of partial mastectomy where an entire quadrant of the breast is removed; C50.x)
Segmentectomy(anatomic subtype; removal of a specific segment of breast tissue, often ductal in nature)
Wire-localized lumpectomy(etiologic/technique subtype; performed when the lesion is non-palpable and requires a guidewire for surgical targeting)
Oncoplastic lumpectomy(related clinical entity; combines oncologic resection with plastic surgery techniques to optimize cosmetic outcomes; Z42.1)
🔗 RELATED TERMS
Mastectomy — the opposite/alternative of lumpectomy; involves the complete surgical removal of the breast tissue (and sometimes underlying muscle), rather than just the tumor and a small margin.
Excisional biopsy — closely related clinical entity; removal of an entire breast mass primarily for diagnostic purposes without the strict requirement for wide, clear margins (CPT 19120).
Sentinel lymph node biopsy (SLNB) — companion diagnostic procedure; removal of the first lymph node(s) to which cancer cells are most likely to spread from a primary tumor, frequently performed concurrently with a lumpectomy.
Lymphadenectomy — complex procedure that overlaps with this term; complete removal of axillary lymph nodes, sometimes performed with a lumpectomy (CPT 19302) if sentinel nodes are positive.
Localization — the physiological/radiological mechanism or process of marking a non-palpable breast lesion (via wire, seed, or magnetic marker) to guide the surgeon during excision.
Oncoplastic — adjective describing surgical techniques that combine oncologic clearance with plastic surgery to sustain or reconstruct breast shape.
Carcinoma in situ — disease entity using this term; early-stage, non-invasive breast cancer (e.g., DCIS) frequently treated with lumpectomy (D05.1x).
Invasive ductal carcinoma (IDC) — malignant disease entity; the most common type of breast cancer, often treated with lumpectomy and radiation (C50.91x).
Mammography — primary diagnostic tool for evaluating breast masses and guiding preoperative localization for this condition.
CODING CORNER
🏥 ICD-10-CM CODES
Malignant Neoplasm of Breast (C50.x — Laterality/Site Required)
Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion (except 19300), open, male or female, 1 or more lesions
Excision of breast lesion identified by preoperative placement of radiological marker, open; each additional lesion separately identified by a preoperative radiological marker (List separately in addition to code for primary procedure)
Placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including mammographic guidance
Placement of breast localization device(s), percutaneous; first lesion, including ultrasound guidance
⚠️ Coding Note: For inpatient and outpatient profee coding, the critical distinction lies between CPT 19120 (excision of a lesion) and 19301 (partial mastectomy/lumpectomy). Code 19301 should only be reported when the provider explicitly documents attention to surgical margins (removing the tumor plus a margin of healthy tissue), typically for a known or highly suspected malignancy. If the documentation merely states “excision of breast mass” without mention of margins, query the provider or default to 19120. Always append laterality modifiers (-RT, -LT) to both the CPT and ICD-10-CM codes. When intraoperative tissue mapping (38900) is performed alongside a sentinel lymph node biopsy (38525), ensure the mapping is separately documented and billable per NCCI edits and payer guidelines. If a patient is admitted as an inpatient for a lumpectomy, it is usually due to significant comorbidities or concurrent major reconstructive procedures; ensure the principal diagnosis reflects the primary reason for the surgical admission (e.g., C50.x).